Pioglitazone & Metformin Sustained Release Tablet

May 18, 2023

PIOSTERIS M 500 

Pioglitazone and metformin sustained-release tablets are a combination medication used to treat type 2 diabetes mellitus. This combination helps to control blood sugar levels by addressing different aspects of the condition.

Pioglitazone belongs to the class of thiazolidinediones and works by improving insulin sensitivity and reducing insulin resistance. Metformin is a biguanide medication that helps decrease glucose production in the liver and improves insulin utilization in the body.

Combining pioglitazone and metformin in a sustained-release tablet formulation allows for a prolonged release of the medications over time, which helps maintain steady blood levels and may improve tolerability.

The dosage strength and recommended dosing frequency of PIOSTERIS M 500  tablets will depend on the specific product prescribed and individual patient factors. Typically, the starting dose is one tablet per day, and the dosage may be adjusted based on blood sugar control and individual response to treatment.

It is essential to follow the instructions provided by your healthcare provider or pharmacist regarding the use of this medication. They will consider factors such as your blood sugar levels, kidney function, and other medications you may be taking when determining the appropriate dosage.

As with any medication, there may be potential side effects or interactions to be aware of. It's important to discuss your medical history and any other medications or supplements you are taking with your healthcare provider to ensure the safe and effective use of pioglitazone and metformin sustained-release tablets.

Remember, this information is not a substitute for medical advice. If you have specific questions or concerns about your medication, consult your healthcare provider or pharmacist.

For further information please contact:

contact@sterispharma.com

Order Now https://www.sterisonline.com/product/piosteris-m-500-134243

SHARE WITH